Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer

Ponnusamy , S , He , Y , Hwang , D-J , Thiyagarajan , T , Houtman , R , Bocharova , V , Sumpter , B G , Fernandez , E , Johnson , D , Du , Z , Pfeffer , L M , Getzenberg , R H , McEwan , I J , Miller , D D & Narayanan , R 2019 , ' Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer ' , Clinical Cancer Research , vol. 25 , no. 22 , pp. 6764-6780 . https://doi.org/10.1158/1078-0432.CCR-19-1458

URI

https://hdl.handle.net/2164/15067

DOI

https://doi.org/10.1158/1078-0432.CCR-19-1458

Rights

This manuscript has been accepted for publication in Clinical Cancer Research, which is published by the American Association for Cancer Research.

Collections

All research


	The Sir Duncan Rice Library University of Aberdeen Bedford Road Aberdeen AB24 3AA Tel: +44 (0)1224 273330 Email: library@abdn.ac.uk